[1]
Günaydın, S. et al. 2026. Factors Affecting Mortality in COVID-19 Pneumonia Patients Treated with Tocilizumab. The European Research Journal. (Mar. 2026), 1–9. DOI:https://doi.org/10.18621/eurj.1829791.